Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nodular lymphocyte predominant Hodgkin's lymphoma in daily practice: A multicenter experience.
Gemici A, Aydogdu I, Terzi H, Sencan M, Aslan A, Kaya AH, Dal MS, Akay MO, Dogu MH, Ayyildiz O, Sahin F, Cagliyan GA, Yilmaz M, Gokgoz Z, Bilen Y, Demir C, Sevindik OG, Korkmaz S, Eser B, Altuntas F; ThREG, Turkish hematology Research and Education Group. Gemici A, et al. Hematol Oncol. 2018 Feb;36(1):116-120. doi: 10.1002/hon.2460. Epub 2017 Jul 14. Hematol Oncol. 2018. PMID: 28707314
A Real-life Turkish Experience of Venetoclax Treatment in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia.
Gemici A, Ozkalemkas F, Dogu MH, Tekinalp A, Alacacioglu I, Guney T, Ince I, Geduk A, Cagliyan GA, Maral S, Serin I, Gunduz E, Karakus V, Bekoz HS, Eren R, Pinar IE, Gunes AK, Sargın FD, Sevindik OG. Gemici A, et al. Clin Lymphoma Myeloma Leuk. 2021 Aug;21(8):e686-e692. doi: 10.1016/j.clml.2021.04.004. Epub 2021 Apr 20. Clin Lymphoma Myeloma Leuk. 2021. PMID: 34059487
Prognostic Factors and Intensive Care Outcome in Post-Transplant Phase of Hematopoietic Stem Cell Transplantation: Intensive Care Outcome in Hematopoietic Stem Cell Transplantation.
Mutlu YG, Aydin BB, Erdogan C, Kizilaslan D, Beköz HS, Gemici A, Kaynar L, Sevindik ÖG. Mutlu YG, et al. Indian J Hematol Blood Transfus. 2023 Apr;39(2):167-172. doi: 10.1007/s12288-022-01575-5. Epub 2022 Oct 11. Indian J Hematol Blood Transfus. 2023. PMID: 37006979 Free PMC article.
Clinical characteristics and therapeutic outcomes of paroxysmal nocturnal hemoglobinuria patients in Turkey: a multicenter experience.
Goren Sahin D, Akay OM, Keklik M, Okan V, Karakus A, Demir C, Erkurt MA, Ilkkilic K, Yildirim R, Akgun Cagliyan G, Aksu S, Dogu MH, Dal MS, Karakus V, Gemici AI, Terzi H, Kelkitli E, Sivgin S, Unal A, Yilmaz M, Ayyildiz O, Korkmaz S, Eser B, Altuntas F. Goren Sahin D, et al. Among authors: gemici ai. Ann Hematol. 2021 Jul;100(7):1667-1675. doi: 10.1007/s00277-021-04554-4. Epub 2021 May 14. Ann Hematol. 2021. PMID: 33988739
Preliminary Report of the Academic CAR-T (ISIKOK-19) Cell Clinical Trial in Turkey: Characterization of Product and Outcomes of Clinical Application.
Erdoğan E, Yalçın K, Hemşinlioğlu C, Sezgin A, Seyis U, Kançağı DD, Taştan C, Yurtsever B, Turan RD, Çakırsoy D, Abanuz S, Sır Karakuş G, Elek M, Bekoz HS, Gemici Aİ, Sargın D, Arat M, Ferhanoğlu B, Pekgüç E, Örnek S, Büyüktaş D, Birgen N, Ratip S, Ovalı E. Erdoğan E, et al. Among authors: gemici ai. Turk J Haematol. 2022 Aug 25;39(3):206-210. doi: 10.4274/tjh.galenos.2022.2022.0193. Epub 2022 Jul 18. Turk J Haematol. 2022. PMID: 35848614 Free PMC article. Clinical Trial.